Aids commentary prophylaxis of pneumocystis carinii pneumonia: An update

Journal of Infectious Diseases

Volumn 160, Issue 5, 1989, Pages 882-886

  Kovacs, Joseph A ^a   Masur, Henry ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; PROTOZOON;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HUMAN; OPPORTUNISTIC INFECTIONS; PNEUMONIA, PNEUMOCYSTIS CARINII; ZIDOVUDINE;

EID: 0024443450     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/160.5.882     Document Type: Article

References (12)

1. Centers for Disease Control. AIDS Weekly Surveillance Report, 30 January 1989;l-5
2. Masur H, Ognibene FP, Yarchoan RY, Shelhamer JH, Baird BF, Travis W, Suffredini AF, Deyton L, Kovacs JA, Fal-loon J, Davey R, Polis M, Metcalf J, Baseler M, Wesley R, Gill VJ, Fauci AS, Lane HC. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus infected individuals. Ann Intern Med 1989;111:223-231
3. Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR 1989;38(No. S-5):l-9
4. Phair J, Munoz A, Detels R, Rinaldo C, Saah A. Incidence of Pneumocystis carinii pneumonia in men infected with human immunodeficiency virus-1 (HIV-1) [abstract M.B.P. 380]. Program and abstracts: V International Conference on AIDS (Montreal). Washington, DC: Bio-Data, 1989
5. Taylor JMG, Fahey JL, Detels R, Giorgi JV. CD4 percent, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J AIDS 1989;2:114-124
6. Parker WA, Hensley RE, Houk RA, Reid MJ. Heterogeneity of the epitopes of CD4 in patients infected with HIV [letter], N Engl J Med 1988;319:581-582
7. Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durack DT, King D, AZT
8. Collaborative Working Group. The efficacy of azidothymi- dine (AZT) in the treatment of patients with AIDS and AIDS related complex. N Engl J Med 1987;317:185-191
9. The Clinical Trial Group represented by Margaret Fischl. The safety and efficacy of two doses of zidovudine in the treatment of patients with AIDS [abstract 3606], Program and Abstracts: IV International Conference on AIDS (Stockholm). Washington, DC: Bio-Data, 1988
10. Fischl MA, Dickinson GM, LaVoie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988;259:1185-1189
11. Leoung GS, Montgomery AB, Abrams DA, Korkery K, Ward-law L, Feigal DW, SF Consortium Physicians. Aerosol pentamidine for pneumocystis pneumonia: a randomized trial of 439 patients [abstract 7166]. Program and abstracts: IV International Conference on AIDS (Stockholm). Washington, DC: Bio-Data, 1988
12. Sattler FR, Cowan R, Nielsen DM, Ruskin J. Trimethoprim sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome—a prospective, noncrossover study. Ann Intern Med 1988;109:280-287